Naylor Stuart
CHIEF SCI OFCR, OPHTHALMOLOGY
Naylor Stuart has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 8, 2026.
On the most recent filing, Naylor Stuart is listed as CHIEF SCI OFCR, OPHTHALMOLOGY at MeiraGTx Holdings plc. Inside the rolling window, Naylor Stuart reported no open-market purchases and 2 open-market sales totaling $668K in MGTX. The largest disclosed transaction in the window is a sale of 27,659 MGTX shares on Jul 7, 2026, worth $409K.
Companies traded
Other insiders at MGTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$668K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Naylor Stuart made?
Naylor Stuart has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Naylor Stuart trade?
Naylor Stuart has filed SEC Form 4 disclosures for 1 company, including MGTX.
When was Naylor Stuart's most recent SEC Form 4 filing?
Naylor Stuart's most recent SEC Form 4 filing on Tracefour is dated Jul 8, 2026.
What is Naylor Stuart's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Naylor Stuart is listed as CHIEF SCI OFCR, OPHTHALMOLOGY.
What is Naylor Stuart's total buy and sell value in the current window?
Inside the rolling retention window, Naylor Stuart bought $0 and sold $668K based on SEC Form 4 filings.
What was Naylor Stuart's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,659 MGTX shares on 2026-07-07, worth $409K, per SEC Form 4 filings.